Molecular heterogeneity in breast carcinoma cells with increased invasive capacities
, , , , , , , , , , , , , , und
14. Feb. 2020
Über diesen Artikel
Artikel-Kategorie: Research Article
Online veröffentlicht: 14. Feb. 2020
Seitenbereich: 103 - 118
Eingereicht: 10. Jan. 2020
Akzeptiert: 30. Jan. 2020
DOI: https://doi.org/10.2478/raon-2020-0007
Schlüsselwörter
© 2020 Giulia Negro, Bertram Aschenbrenner, Simona Kranjc Brezar, Maja Cemazar, Andrej Coer, Gorana Gasljevic, Dragana Savic, Maxim Sorokin, Anton Buzdin, Maurizio Callari, Irma Kvitsaridze, Anahid Jewett, Mariela Vasileva-Slaveva, Ute Ganswindt, Ira Skvortsova, Sergej Skvortsov, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Negro, Giulia
Medical University of Innsbruck, Therapeutic Radiology and OncologyInnsbruck, Austria
Tyrolean Cancer Research InstituteInnsbruck, Austria
EORTC PathoBiology GroupBrussels, Belgium
Aschenbrenner, Bertram
Medical University of Innsbruck, Therapeutic Radiology and OncologyInnsbruck, Austria
Tyrolean Cancer Research InstituteInnsbruck, Austria
EORTC PathoBiology GroupBrussels, Belgium
Brezar, Simona Kranjc
Department of Experimental Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
Cemazar, Maja
Department of Experimental Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
University of Primorska, Faculty of Health SciencesIzola, Slovenia
EORTC PathoBiology GroupBrussels, Belgium
Coer, Andrej
University of Primorska, Faculty of Health SciencesIzola, Slovenia
Orthopaedic Hospital ValdoltraAnkaran, Slovenia
Gasljevic, Gorana
Department of Experimental Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
Savic, Dragana
Medical University of Innsbruck, Therapeutic Radiology and OncologyInnsbruck, Austria
Tyrolean Cancer Research InstituteInnsbruck, Austria
EORTC PathoBiology GroupBrussels, Belgium
Sorokin, Maxim
Shemyakin-Ovchinnikov Institute of Bioorganic ChemistryMoscow, Russia
I.M. Sechenov First Moscow State Medical UniversityMoscow, Russia
Omicsway CorpWalnut, USA
EORTC PathoBiology GroupBrussels, Belgium
Buzdin, Anton
Shemyakin-Ovchinnikov Institute of Bioorganic ChemistryMoscow, Russia
I.M. Sechenov First Moscow State Medical UniversityMoscow, Russia
Oncobox ltdMoscow, Russia
EORTC PathoBiology GroupBrussels, Belgium
Callari, Maurizio
Cancer Research UK Cambridge Institute, University of CambridgeCambridge, UK
EORTC PathoBiology GroupBrussels, Belgium
Kvitsaridze, Irma
Medical University of Innsbruck, Therapeutic Radiology and OncologyInnsbruck, Austria
Tyrolean Cancer Research InstituteInnsbruck, Austria
EORTC PathoBiology GroupBrussels, Belgium
Jewett, Anahid
Division of Oral Biology and Medicine Microbiology, Immunology, & Molecular Genetics, Tumor Immunology Laboratory, College of Letters & Science, UCLA School of Dentistry and MedicineLos Angeles, USA
Vasileva-Slaveva, Mariela
Medical University of Innsbruck, Therapeutic Radiology and OncologyInnsbruck, Austria
Tyrolean Cancer Research InstituteInnsbruck, Austria
EORTC PathoBiology GroupBrussels, Belgium
Ganswindt, Ute
Medical University of Innsbruck, Therapeutic Radiology and OncologyInnsbruck, Austria
Skvortsova, Ira
Medical University of Innsbruck, Therapeutic Radiology and OncologyInnsbruck, Austria
Tyrolean Cancer Research InstituteInnsbruck, Austria
EORTC PathoBiology GroupBrussels, Belgium
Skvortsov, Sergej
Medical University of Innsbruck, Therapeutic Radiology and OncologyInnsbruck, Austria
Tyrolean Cancer Research InstituteInnsbruck, Austria